Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine.
Pharmaceuticals (Basel)
; 10(2)2017 Mar 30.
Article
em En
| MEDLINE
| ID: mdl-28358322
ABSTRACT
A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article